-

OBIO® and IPON Renew Multi-Year Collaboration to Advance Ontario’s Sovereign IP Capacity

TORONTO--(BUSINESS WIRE)--OBIO® and Intellectual Property Ontario (IPON) have renewed their memorandum of understanding (MOU) to ensure that Ontario’s next generation of companies developing innovative human health products continue to access optimal intellectual property (IP) protection and commercialization support.

Through this agreement, OBIO® and IPON will continue to jointly assist Ontario’s early-stage life sciences and health technology companies with IP development and commercialization strategies. The collaboration builds on an established partnership from 2024, and now qualified OBIO® referrals will be eligible for fast-tracking for IPON’s support and funding. The two organizations have been committed to working together as appropriate to co-host IP capacity‑building events and joint visibility initiatives. Together, early-stage companies in the sector will be well-positioned to build strong IP strategies.

Since its inception in 2009, OBIO® has been dedicated to creating programs for life sciences and health technology companies that strengthen Ontario’s IP, support early-stage companies in achieving procurement within Canadian healthcare systems, attract investment to grow the sector, drive economic development, and protect the province’s self-sufficiency.

IPON is a provincial agency established in 2022 that provides IP support and services to help Ontario businesses and researchers innovate and scale.

This renewed agreement will ensure long‑term alignment on maintaining and strengthening sovereign IP retention.

Quotes:

“In the face of economic uncertainty, it is crucial for our government to protect and drive our homegrown life sciences discoveries that strengthen our economy. Our government commends this innovative partnership between Intellectual Property Ontario and OBIO®, which will ensure more world-class life sciences businesses have the tools they need to commercialize discoveries that save and improve lives across Ontario.” —Nolan Quinn, Minister of Colleges, Universities, Research Excellence and Security

“Protecting and strengthening Ontario’s sovereign IP is fundamental to building a competitive and self‑sustaining life sciences sector. Our renewed collaboration with IPON ensures that early‑stage companies have the strategic guidance and support needed to safeguard their innovations, accelerate commercialization, and provide the necessary conditions to anchor, grow and scale in Ontario. Together, we are creating the environment for Ontario‑made health technologies to succeed at home and compete on the global stage.” —Dr. Maura Campbell, President & CEO, OBIO®

“Deepening our collaboration with OBIO® leverages our respective experts and strengthens Ontario’s innovation ecosystem to the collective benefit of our shared clients in the health care sector. By working closely with OBIO®, we’re ensuring that emerging life sciences companies have the IP expertise they need to move forward with confidence and build long‑term value in the province.” —Paul Paolatto, Interim CEO, IPON

About OBIO®

Founded in 2009, OBIO® is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to address the needs of the next generation of companies developing innovative human health products. OBIO® supports early-stage and venture-backed life sciences and health tech companies enabling them to raise capital, hire and train industry-ready talent, facilitate the commercialization and market adoption of their technologies in health systems, and access infrastructure. OBIO® advances this goal through collaborative partnerships with industry, the investment community, academia, the healthcare system and government. For more information, please visit obio.ca and follow OBIO® on LinkedIn and X.

About Intellectual Property Ontario (IPON)

Intellectual Property Ontario (IPON) is a provincial agency that provides trusted IP support and services to enable Ontario businesses and researchers to innovate and grow. IPON works directly with innovators and postsecondary institutions to help them better understand how to protect and maximize the value of their IP, strengthen their capacity to grow and compete in the market, and advance the province’s economic growth. For more information, please visit www.ip-ontario.ca and follow IPON on LinkedIn and X.

Contacts

Media Contacts:

Laura Bunn
Intellectual Property Ontario (IPON)
Manager, Communications
communications@ip-ontario.ca

Doriane Rey
OBIO®
Senior Manager, Marketing & Communications
dorianerey@obio.ca

OBIO


Release Versions

Contacts

Media Contacts:

Laura Bunn
Intellectual Property Ontario (IPON)
Manager, Communications
communications@ip-ontario.ca

Doriane Rey
OBIO®
Senior Manager, Marketing & Communications
dorianerey@obio.ca

Social Media Profiles
More News From OBIO

OBIO® Celebrates Women Leaders in Life Sciences and Health Tech with Investment in Block Biosciences and Launch of Entrepreneurship Training Program for Women in STEM

TORONTO--(BUSINESS WIRE)--In honour of International Women’s Month, OBIO® hosted a celebration of women leaders across the life sciences and health tech sectors. The event, supported by EY and FACIT, featured remarks by Chi Nguyen, Member of Parliament for Spadina — Harbourfront, and The Honourable Charmaine Williams, Associate Minister of Women’s Social and Economic Opportunity, a panel discussion on raising capital and scaling globally, and a pitch competition showcasing the nine women-led co...

Esprit-ai, Perley Health and OBIO® Advance Dementia Care to Support Seniors and Veterans in Long-Term Care Homes

TORONTO & OTTAWA, Ontario--(BUSINESS WIRE)--Long-term care residents with dementia often face heightened vulnerability due to complex health histories, cognitive decline, and mobility challenges. Risks such as falls, agitation, and unsafe interactions remain persistent concerns in long-term care. Esprit-ai is proud to announce that Perley Health will move forward with the procurement of the Esprit-ai Sense™ AI-powered monitoring system after a successful evaluation at the Perley Health Centre o...

OBIO® supports Trexo Robotics to Help Young Patients Walk at McMaster Children’s Hospital

TORONTO--(BUSINESS WIRE)--In North America, 250,000 children are unable to walk due to central nervous system injuries or neurological conditions, such as cerebral palsy. An effective physical therapy for children with injuries or disabilities affecting their motor skills requires an innovative solution that can build muscle memory and stimulate neuroplasticity. With support from OBIO®, Hamilton Health Sciences’ (HHS) McMaster Children’s Hospital has a new tool, the Trexo Plus, designed by Miss...
Back to Newsroom